The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study
Open accessAbstract
Objective: To determine the effect of opioid and stimulant Risk Mitigation Guidance (RMG) dispensations on mortality and acute care visits during the dual public health emergencies of overdose and covid-19. Design: Population based retrospective cohort study. Setting: British Columbia, Canada. Participants: 5882 people with opioid or stimulant use disorder who received RMG prescriptions for opioids (n=5356) and/or stimulants (n=1061) (535 received both) from 27 March 2020 to 31 August 2021. Main outcome measures: All cause and overdose specific mortality and acute care visits in the week after RMG opioid or stimulant dispensation. RMG recipients were matched 1:1 with controls through use of high dimensional propensity score matching. Marginal structural models, executed on weekly time steps, were used to measure the effect of dispensations on outcomes. Results: RMG opioid dispensations of one day or more were associated with reduced all cause mortality (adjusted hazard ratio 0.39, 95% confidence interval 0.25 to 0.60) and overdose related mortality (0.45, 0.27 to 0.75) in the subsequent week. Dispensations of RMG stimulants (≥1 days) were not significantly associated with reduced all cause mortality (adjusted hazard ratio 0.50, 0.20 to 1.23) or overdose related mortality (0.53, 0.18 to 1.56). The protective effect of RMG opioid dispensations increased with the number of days the medications were dispensed in a given week. People who received four or more days of RMG opioid dispensations had reduced all cause mortality (adjusted hazard ratio 0.09, 0.04 to 0.21) and overdose related mortality (0.11, 0.04 to 0.32) compared with the control group. Opioid RMG dispensations did not significantly modify the odds of all cause or overdose related acute care visits. Dispensations of RMG stimulants were associated with a significant decrease in the odds of acute care visits for any cause but did not affect the odds of overdose related acute care visits. Conclusions: RMG opioid dispensations were associated with reduced overdose related and all cause mortality among a sample of people with opioid use disorder. Pharmaceutical alternatives to the illegal drug supply are promising interventions to reduce mortality in people with opioid use disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The finding of an increase in opioid hospitalizations and no significant change in opioid-related deaths during the safer supply period differ from the reduction in opioid overdose deaths reported by Slaunwhite et al.8”
From Safer Opioid Supply, Subsequent Drug Decriminalization, and Opioid Overdoses (2025) · cites this paper as Slaunwhite et al.8
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“29 We used an SAS macro version 2 (available at www.drugepi.org) for high dimensional propensity score covariate selection and matching.”
MethodMarginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Austin, P. C. (2011) · Pharmaceutical Statistics · doi:10.1002/pst.433 · Cited by 3,949 · cited 1×
“28 We assessed the distributions of covariates before and after matching by the high dimensional propensity score by using standardised mean differences between the exposed and unexposed groups.”
MethodHernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,782
D'Agostino, R. B., Lee, M., Belanger, A. J., Cupples, L. A., Anderson, K., & Kannel, W. B. (1990) · Statistics in Medicine · doi:10.1002/sim.4780091214 · Cited by 798
Craig, P., Katikireddi, S. V., Leyland, A., & Popham, F. (2017) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031816-044327 · Cited by 570
Leatherdale, S. T. (2019) · International Journal of Social Research Methodology · doi:10.1080/13645579.2018.1488449 · Cited by 328
Konstenius, M., Jayaram‐Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014) · Addiction · doi:10.1111/add.12369 · Cited by 188
PARK, J. N., ROUHANI, S., BELETSKY, L., VINCENT, L., SALONER, B., & SHERMAN, S. G. (2020) · The Milbank Quarterly · doi:10.1111/1468-0009.12470 · Cited by 163
Cited by
Prescribed safer opioid supply: A scoping review of the evidence
Ledlie, S., Garg, R., Cheng, C., Kolla, G., Antoniou, T., Bouck, Z., & Gomes, T. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104339 · Cited by 68
The public health risks of counterfeit pills
Friedman, J., & Ciccarone, D. (2025) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00273-1 · Cited by 32
Kolla, G., Pauly, B., Cameron, F., Hobbs, H., Ranger, C., McCall, J., Majalahti, J., Toombs, K., LeMaistre, J., Selfridge, M., et al. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01029-3 · Cited by 21
Self-citationMarkoulidakis, A., Hickman, M., McAuley, A., Barnsdale, L. R., Welton, N. J., Glancy, M., Shivaji, T., Collins, C., Lang, J., de Wit, F., et al. (2024) · Addiction · doi:10.1111/add.16500 · Cited by 15
Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt
Min, J. E., Guerra‐Alejos, B. C., Yan, R., Palis, H., Barker, B., Urbanoski, K. A., Pauly, B., Slaunwhite, A., Bach, P., Ranger, C., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.11389 · Cited by 20
Self-citation
Metadata
- Authors
- Slaunwhite, A., Min, J. E., Palis, H., Urbanoski, K., Pauly, B., Barker, B., Crabtree, A., Bach, P., Krebs, E., Dale, L., Meilleur, L., & Nosyk, B.
- Affiliations
- University of British Columbia (CA)
- Centre for Advancing Health Outcomes (CA)
- University of Victoria (CA)
- Simon Fraser University (CA)
- BC Cancer Agency (CA)
- First Nations Health Authority (CA)
- Corresponding author
- Nosyk, Bohdan
- ORCID
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2024-01-10
- Volume
- 384
- Pages
- e076336
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W4390718539
- Cited by
- 100
- References
- 40
- Citations by year
- 2026: 17 · 2025: 43 · 2024: 40
- FWCI
- 41.42
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-03-11)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BMJ (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- UVic’s Research and Learning Repository (University of Victoria) (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- opioid use disorder, stimulant use disorder, drug overdose deaths, all-cause mortality, acute care visits, COVID-19 pandemic, public health emergencies, harm reduction, British Columbia
- MeSH terms
- Central Nervous System Stimulants, Analgesics, Opioid, British Columbia, Emergencies, Humans, Opioid-Related Disorders, Public Health, Retrospective Studies, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. https://app.cochat.ai/papers/10.1136/bmj-2023-076336
- The paper
- Slaunwhite, A., Min, J. E., Palis, H., Urbanoski, K., Pauly, B., Barker, B., Crabtree, A., Bach, P., Krebs, E., Dale, L., Meilleur, L., & Nosyk, B. (2024). Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ. https://doi.org/10.1136/bmj-2023-076336
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.